RenovoRx Inc. Insider Trading

RNXT

⊜ Compare

Last 12 months

Insiders bought 84K on the open market and sold nothing.

Net open-market

+84K

12 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

4 / 0

executives and directors

Last open-market buy

May 2026

May 19, 2026

Get an email when RNXT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 19	Mark Voll Chief Financial Officer	Bought	25,000	$0.79	20K	12%	Form 4
Mar 20	Laurence Marton Director	Bought	9,720	—	—	New	Form 4
Mar 20	Shaun Bagai Chief Executive Officer	Bought	24,300	—	—	7.1%	Form 4
Mar 20	Mark Voll Chief Financial Officer	Bought	97,200	—	—	New	Form 4
Jan 21	Ramtin Agah Chief Medical Officer	Bought	10,000	$1.00	10K	1.3%	Form 4
Dec 31, 2025	Ramtin Agah Chief Medical Officer	Bought	9,795	$0.86	8K	1.3%	Form 4
Dec 30, 2025	Ramtin Agah Chief Medical Officer	Bought	205	$0.83	$170	<0.1%	Form 4
Dec 18, 2025	Shaun Bagai Chief Executive Officer	Bought	5,000	$0.90	5K	1.5%	Form 4
Dec 17, 2025	Shaun Bagai Chief Executive Officer	Bought	5,000	$0.85	4K	1.5%	Form 4
Dec 16, 2025	Ramtin Agah Chief Medical Officer	Bought	12,000	$0.85	10K	1.6%	Form 4
Dec 5, 2025	Ramtin Agah Chief Medical Officer	Bought	10,000	$0.96	10K	1.3%	Form 4
Nov 21, 2025 – Nov 24, 2025	Ramtin Agah Chief Medical Officer	Bought 2 parts	22,000	$0.80 average	18K	3.0%	Form 4
Aug 22, 2025 – Aug 25, 2025	Shaun Bagai Chief Executive Officer	Bought 2 parts	10,000	$0.93 average	9K	3.1%	Form 4
Jun 5, 2025	Ramtin Agah Chief Medical Officer	Bought	21,000	$1.40	29K	2.9%	Form 4
Apr 15, 2025	Ramtin Agah Chief Medical Officer	Bought	15,000	$0.90	14K	1.4%	Form 4
Apr 15, 2025	Shaun Bagai Chief Executive Officer	Bought	7,500	$0.91	7K	2.4%	Form 4
Apr 11, 2025	Ramtin Agah Chief Medical Officer	Bought	20,000	$0.80	16K	1.9%	Form 4
Apr 8, 2025 – Apr 10, 2025	Ron Kocak VP Controller and PAO	Bought 3 parts	12,595	$0.79 average	10K	New	Form 4
Apr 9, 2025	Ramtin Agah Chief Medical Officer	Bought	30,000	$0.81	24K	2.9%	Form 4
Apr 9, 2025	Shaun Bagai Chief Executive Officer	Bought	10,000	$0.83	8K	3.3%	Form 4
Apr 8, 2025	Laurence Marton Director	Bought	12,050	$0.85	10K	36%	Form 4
Apr 8, 2025	Ramtin Agah Chief Medical Officer	Bought	26,000	$0.84	22K	2.5%	Form 4
Apr 7, 2025	Shaun Bagai Chief Executive Officer	Bought	10,000	$0.83	8K	3.4%	Form 4

May 19
Mark Voll
Chief Financial Officer · bought 25,000 at $0.79
20K
12% of stake
Mar 20
Laurence Marton
Director · bought 9,720
—
New position
Mar 20
Shaun Bagai
Chief Executive Officer · bought 24,300
—
7.1% of stake
Mar 20
Mark Voll
Chief Financial Officer · bought 97,200
—
New position
Jan 21
Ramtin Agah
Chief Medical Officer · bought 10,000 at $1.00
10K
1.3% of stake
Dec 31, 2025
Ramtin Agah
Chief Medical Officer · bought 9,795 at $0.86
8K
1.3% of stake
Dec 30, 2025
Ramtin Agah
Chief Medical Officer · bought 205 at $0.83
$170
<0.1% of stake
Dec 18, 2025
Shaun Bagai
Chief Executive Officer · bought 5,000 at $0.90
5K
1.5% of stake
Dec 17, 2025
Shaun Bagai
Chief Executive Officer · bought 5,000 at $0.85
4K
1.5% of stake
Dec 16, 2025
Ramtin Agah
Chief Medical Officer · bought 12,000 at $0.85
10K
1.6% of stake
Dec 5, 2025
Ramtin Agah
Chief Medical Officer · bought 10,000 at $0.96
10K
1.3% of stake
Nov 21, 2025 – Nov 24, 2025
Ramtin Agah
Chief Medical Officer · bought 22,000 at avg $0.80
18K
3.0% of stake
Aug 22, 2025 – Aug 25, 2025
Shaun Bagai
Chief Executive Officer · bought 10,000 at avg $0.93
9K
3.1% of stake
Jun 5, 2025
Ramtin Agah
Chief Medical Officer · bought 21,000 at $1.40
29K
2.9% of stake
Apr 15, 2025
Ramtin Agah
Chief Medical Officer · bought 15,000 at $0.90
14K
1.4% of stake
Apr 15, 2025
Shaun Bagai
Chief Executive Officer · bought 7,500 at $0.91
7K
2.4% of stake
Apr 11, 2025
Ramtin Agah
Chief Medical Officer · bought 20,000 at $0.80
16K
1.9% of stake
Apr 8, 2025 – Apr 10, 2025
Ron Kocak
VP Controller and PAO · bought 12,595 at avg $0.79
10K
New position
Apr 9, 2025
Ramtin Agah
Chief Medical Officer · bought 30,000 at $0.81
24K
2.9% of stake
Apr 9, 2025
Shaun Bagai
Chief Executive Officer · bought 10,000 at $0.83
8K
3.3% of stake
Apr 8, 2025
Laurence Marton
Director · bought 12,050 at $0.85
10K
36% of stake
Apr 8, 2025
Ramtin Agah
Chief Medical Officer · bought 26,000 at $0.84
22K
2.5% of stake
Apr 7, 2025
Shaun Bagai
Chief Executive Officer · bought 10,000 at $0.83
8K
3.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RNXT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with RNXT

CompareIntrinsic value

VTAKCatheter Precision, Inc.

$0.56-5.08%40

OSRHOsr Holdings Inc.

$0.16-5.88%10

VYCOVycor Medical Inc.

$0.05-3.85%50

ICUSeastar Medical Holding Corporation

$2.04+2.00%20

FEMYFemasys Inc.

$1.44+2.86%30

EBRCZEBR Systems, Inc.

$0.08+0.00%0

SINTSintx Technologies Inc.

$1.66-3.49%10

PLSEPulse Biosciences, Inc.

$57.06+9.31%40

Spot a number that looks wrong? Check it in RNXT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RNXT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.